Concepedia

Kazunori Ohba

KO

8

Publications

193

Citations

8

H-Index

1979

Active since

Affiliations

Central Research Laboratories (United Kingdom)(Current)

Unitika (Japan)

BioScience Laboratories (United States)

Kazunori Ohba is an author at Central Research Laboratories (United Kingdom) specializing in medicine, drug resistance, and antibiotics.

Top concepts

MedicineAntibioticsDrug ResistanceAntimicrobial ResistancePharmacologyAntimicrobial Drug DiscoveryMicrobiologyHealthDrug DiscoveryMedicinal Chemistry

Publications per year

1979–1988

8

Publications

8

Pyrindamycins A and B, new antitumor antibiotics.

Kazunori Ohba, Hiroomi Watabe, Tōru Sasaki et al. · The Journal of Antibiotics · 1988 · 51 citations · Full text

Medicinal Chemistry, New Antitumor Antibiotics, Antibiotics +9

Studies on a new aminoglycoside antibiotic, dactimicin II. Isolation, structure and chemical degradation.

Kazunori Ohba, Takashi Tsuruoka, Kazuko Mizutani et al. · The Journal of Antibiotics · 1981 · 37 citations · Full text

A novel aminoglycoside antibiotic, substance SF-2052.

Shigeharu Inouye, Kazunori Ohba, TAKASHI SHOMURA et al. · The Journal of Antibiotics · 1979 · 26 citations · Full text

Medicinal Chemistry, Antimicrobial Drug Discovery, Antibiotics +9

A new antiviral antibiotic SF-2140 produced by Actinomadura.

Tatsuo Ito, Kazunori Ohba, M. Koyama et al. · The Journal of Antibiotics · 1984 · 24 citations · Full text

Antimicrobial Drug Discovery, Antibiotics, Antimicrobial Chemotherapy +5

A novel .BETA.-lactamase inhibitor, SF-2103 a produced by a Streptomyces.

Tatsuo Ito, Norio Ezaki, Kazunori Ohba et al. · The Journal of Antibiotics · 1982 · 21 citations

Antimicrobial Drug Discovery, Antimicrobial Susceptibility, Health Sciences +11

Rows per page

1–5 of 8